Characterization of ovarian clear cell carcinoma using target drug-based molecular biomarkers: implications for personalized cancer therapy

BACKGROUND: It has long been appreciated that different subtypes (serous, clear cell, endometrioid and mucinous) of epithelial ovarian carcinoma (EOC) have distinct pathogenetic pathways. However, clinical management, especially chemotherapeutic regimens, for EOC patients is not subtype specific. Ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mengjiao, Li, Haoran, Liu, Fei, Bi, Rui, Tu, Xiaoyu, Chen, Lihua, Ye, Shuang, Cheng, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303290/
https://www.ncbi.nlm.nih.gov/pubmed/28187748
http://dx.doi.org/10.1186/s13048-017-0304-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5303290/
https://www.ncbi.nlm.nih.gov/pubmed/28187748
http://dx.doi.org/10.1186/s13048-017-0304-9

Ejemplares similares